Author Interview: Doctor Chung-Mao Kao, May 2026
About this episode
Professor Peter Nash interviews Doctor Chung-Mao Kao about a study on malignancy risk in rheumatoid arthritis patients using biological drugs.
Join Professor Peter Nash from the Griffith University in Brisbane, and Doctor Chung-Mao Kao from Taichung Veterans General Hospital, as they discuss the recent publication ‘Malignancy risk in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: A 5-year population-based cohort study’.
More episodes of The IMID Forum
- Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA
- Author Interview: Dr Murat Torgutalp, June 2026
- Discussing RA: Infectious complications of RA treatments
- Discussing PsA: Personalising treatment targets – understanding clinically meaningful improvement
Explore listener stats, chart rankings, contacts and more on the The IMID Forum podcast page.